Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813836 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mariya Gryaznova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Microbiota. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Emerging evidence suggests that the reproductive tract microbiota is a key modulator of local inflammatory and immune pathways throughout pregnancy and may subsequently impact pregnancy outcomes. In this study, our objective was to analyze the cervical and vaginal microbiomes during early pregnancy among three groups: women with healthy ongoing pregnancies, women undergoing dydrogesterone treatment, and those who experienced miscarriages. The experiment involved 51 women at 8–11 weeks of gestation. The microbiome was examined using 16S rRNA sequencing on the Ion Torrent PGM platform. Across all groups, Lactobacillus iners was predominant, suggesting that the vaginal community type CST III is common among the majority of participants. Notably, our data highlighted the significant roles of Gardnerella vaginalis and Mycoplasma girerdii in the pathogenesis of early miscarriage. Conversely, L. iners and Bifidobacterium longum have a protective effect in early pregnancy. Moreover, dydrogesterone intake appeared to influence notable differences between the cervical and vaginal microbiomes. Overall, our study enhanced our understanding of the cervical and vaginal microbiome composition in the eastern European population during early pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia.
- Antenatal Care Department, Yakovlevo Central District Hospital, 309070 Stroitel, Russia.
- Department of Genetics, Cytology and Bioengineering, Voronezh State University, 394018 Voronezh, Russia.
- Department of Genetics, Albert Einstein College of Medicine, New York, NY 10461, USA.
- Department of Obstetrics and Gynecology, Belgorod State National University, 308015 Belgorod, Russia.
ORCID-Profile: Mariya Gryaznova, Yuliya Smirnova, Inna Burakova, Olga Lebedeva
Förderung
- Russian Science Foundation
Zitieren
APA
Gryaznova, M., Kozarenko, O., Smirnova, Y., Burakova, I., Syromyatnikov, M., Maslov, A., & Lebedeva, O. (2023). Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813836
Vancouver
Gryaznova M, Kozarenko O, Smirnova Y, Burakova I, Syromyatnikov M, Maslov A, et al. Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813836
BibTeX
@article{Gryaznova2023,
author = {Gryaznova, Mariya and Kozarenko, Olesya and Smirnova, Yuliya and Burakova, Inna and Syromyatnikov, Mikhail and Maslov, Alexander and Lebedeva, Olga},
title = {Cervical and Vaginal Microbiomes in Early Miscarriages and Ongoing Pregnancy with and without Dydrogesterone Usage},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813836}
}
EUVIMED